Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer

Completed · Phase 3

Conditions studied: Adenocarcinoma

In brief

The purpose of this study is to compare two combinations of drugs, epirubicin given with a taxane (ET) or epirubicin given with cyclophosphamide (cytoxan) and followed by a taxane to see if one of the combinations is better at preventing or delaying the time for breast cancer recurrence and death after 3 years. The study will also evaluate the side effects of both treatment combinations.

Key facts

Study ID

NCT00140075

Run by

Pfizer

People needed

606

Starts

2000-11-01

Expected to finish

2006-08-01

Last updated by the study team

2011-05-26

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Breast Cancer Stage T1-3, N1, M0
• Suitable candidate for anthracycline-containing adjuvant chemotherapy

You may not qualify if…

• Evidence of residual tumor following surgery, or metastatic disease
• Received prior therapy for breast cancer

Where it is running

• Pfizer Investigational Site — Tucson, Arizona, United States
• Pfizer Investigational Site — Bakersfield, California, United States
• Pfizer Investigational Site — Berkeley, California, United States
• Pfizer Investigational Site — Fountain Valley, California, United States
• Pfizer Investigational Site — Fountian Valley, California, United States
• Pfizer Investigational Site — Gilroy, California, United States
• Pfizer Investigational Site — Poway, California, United States
• Pfizer Investigational Site — Soquel, California, United States
• Pfizer Investigational Site — Colorado Springs, Colorado, United States
• Pfizer Investigational Site — Jacksonville, Florida, United States
• Pfizer Investigational Site — Jacksonville, Florida, United States
• Pfizer Investigational Site — Kissimmee, Florida, United States
• Pfizer Investigational Site — Lake Worth, Florida, United States
• Pfizer Investigational Site — Lecanto, Florida, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Miami Shores, Florida, United States
• Pfizer Investigational Site — Port Saint Lucie, Florida, United States
• Pfizer Investigational Site — Tampa, Florida, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Macon, Georgia, United States
• Pfizer Investigational Site — Belleville, Illinois, United States
• Pfizer Investigational Site — Skokie, Illinois, United States
• Pfizer Investigational Site — Baton Rouge, Louisiana, United States
• Pfizer Investigational Site — New Orleans, Louisiana, United States
• Pfizer Investigational Site — Mobile, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.